- Home
- RIGL vs FREY Comparison
RIGL vs FREY Comparison
Compare RIGL & FREY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- FREY
- Stock Information
- Founded
- RIGL 1996
- FREY 2018
- Country
- RIGL United States
- FREY Luxembourg
- Employees
- RIGL N/A
- FREY N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- FREY Industrial Machinery/Components
- Sector
- RIGL Health Care
- FREY Miscellaneous
- Exchange
- RIGL Nasdaq
- FREY Nasdaq
- Market Cap
- RIGL 247.1M
- FREY 293.4M
- IPO Year
- RIGL 2000
- FREY N/A
- Fundamental
- Price
- RIGL $25.04
- FREY $2.54
- Analyst Decision
- RIGL Buy
- FREY
- Analyst Count
- RIGL 5
- FREY 0
- Target Price
- RIGL $31.30
- FREY N/A
- AVG Volume (30 Days)
- RIGL 288.9K
- FREY 6.3M
- Earning Date
- RIGL 11-07-2024
- FREY 11-06-2024
- Dividend Yield
- RIGL N/A
- FREY N/A
- EPS Growth
- RIGL N/A
- FREY N/A
- EPS
- RIGL 0.22
- FREY N/A
- Revenue
- RIGL $157,374,000.00
- FREY N/A
- Revenue This Year
- RIGL $38.26
- FREY N/A
- Revenue Next Year
- RIGL $24.21
- FREY $414.23
- P/E Ratio
- RIGL $109.79
- FREY N/A
- Revenue Growth
- RIGL 21.65
- FREY N/A
- 52 Week Low
- RIGL $7.48
- FREY $0.91
- 52 Week High
- RIGL $29.82
- FREY $2.85
- Technical
- Relative Strength Index (RSI)
- RIGL 68.80
- FREY 66.18
- Support Level
- RIGL $22.33
- FREY $2.07
- Resistance Level
- RIGL $29.16
- FREY $2.40
- Average True Range (ATR)
- RIGL 2.30
- FREY 0.29
- MACD
- RIGL 0.41
- FREY 0.04
- Stochastic Oscillator
- RIGL 69.96
- FREY 86.06
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About FREY FREYR Battery Inc.
FREYR Battery Inc is an emerging producer of clean battery solutions for the planet. It designs and manufactures high-density and cost-competitive lithium-ion batteries with a reduced carbon footprint for the markets for electric mobility, stationary energy storage, and marine and aviation applications.